NCT03165188终止不适用
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 29
- 试验地点
- 15
- 主要终点
- Proportion of subjects with adverse events.
研究概览
简要总结
This protocol (NLG0705) provides a mechanism for the 15-year follow-up period that the FDA requires for all participants in gene transfer protocols and assures that adequate follow-up can be maintained for subjects who have received at least one dose of algenpantucel-L.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Receipt of at least one dose of algenpantucel-L within the past 15 years
- •Signed consent
排除标准
- 未提供
结局指标
主要结局
Proportion of subjects with adverse events.
时间窗: Up to 15 years
Survival
时间窗: Up to 15 years
次要结局
未报告次要终点
研究者
研究点 (15)
Loading locations...
相似试验
已完成
不适用
Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked ProductsSevere Combined ImmunodeficiencyMalignancy, HematologicMucopolysaccharidosis INeuroblastomaNeoplasmNCT00695279St. Jude Children's Research Hospital41
已完成
4 期
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up StudiesMultiple SclerosisNCT03269175Bayer261
进行中（未招募）
3 期
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)2024-512580-31-00Sangamo Therapeutics Inc.20
已完成
不适用
A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)VaricellaHerpes ZosterNCT01077804Merck Sharp & Dohme LLC7,585
已完成
不适用
Long-Term Follow-up Study for Patients Previously Treated With JCAR015Acute Lymphoblastic LeukemiaNCT02813252Juno Therapeutics, a Subsidiary of Celgene15